mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.009 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.009 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.009 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |